1. Pink Sheet
  2. >>Geography
  3. >>Europe

J&J Trims Formaldehyde-Releasing Chemicals In Personal Care Items

 
• By Suzanne Blecher

In response to consumer demand, J&J will remove controversial ingredients from both baby and adult brands, including Aveeno, Clean & Clear, Lubriderm and Neutrogena.

Johnson & Johnson will eliminate or reduce the levels of formaldehyde, phthalates and triclosan in its baby and adult personal care products by the end of 2015 in response to consumer demand.

“We’re doing this because we’re listening to the people who rely on our products, and if they have concerns we’re committed to addressing them, as long as we can do so safely and effectively,” says Susan

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

What The EMA Can Teach HTA Bodies About Joint Clinical Assessments

 
• By Francesca Bruce

EU-level joint clinical assessments conducted under the Health Technology Assessment Regulation need to be more flexible when it comes to evidence requirements, according to experts speaking at a gene and cell therapy conference.

Moderna Pivots To Increase Focus On Cancer Amid US Vaccine Policy Changes

 
• By Joseph Haas

During its first quarter earnings call, Moderna avoided criticizing vaccine policy changes, but de-emphasized its flu/COVID-19 vaccine for those under age 50 and prioritized cancer programs.

What MAHA Means For US FDA: Prevention Is Not What You Think

 
• By Michael McCaughan

US HHS Advisor Calley Means said new pathways for root-cause treatments are part of the HHS Secretary Robert F. Kennedy Jr.’s vision for the FDA. But what most biopharma companies consider preventative medicines are not what he has in mind, nor does he seem to see those companies as part of the solution.